SaO003REAL WORLD EXPERIENCE OF RENAL DENERVATION: THE UK RENAL DENERVATION AFFILIATION REPORT

  • Dasgupta I
  • Mark P
  • Burchell A
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Introduction and Aims: Renal denervation (RDN) may lower blood pressure (BP) in people with resistant hypertension. Here we report the combined UK experience of RDN. Methods: The UK Renal Denervation Affiliation is an independent investigator-led initiative of 16 centres, each had done >5 cases. A standardized dataset was collected retrospectively, anonymised and submitted to the coordinating centre for analysis. Results: 246 cases from 16 centres are reported. The average number of cases per centre was 15. Five different ablation technologies were used; unipolar catheters in 198 and multipolar in 48. The mean age was 56.7 years, 53% female, 87% Caucasian, and diabetes 27%. 24% percent patients had previous stroke, 15% myocardial infarction, and 26% had proteinuria. Patients were selected in accordance with the Joint UK Societies Consensus Statement 2012, by multi-disciplinary teams; 86% attended specialist hypertension clinics. On average 4.7 drugs were used before RDN; 95% were on ≥3drugs; 90% RAS blockers and diuretics, and 56% aldosterone antagonists. Pre-RDN mean office BP was 186/102 mmHg. Ambulatory blood pressure monitoring (ABPM) data were available for 179 patients (73%). Average day ABP was 170/98; night ABP was 154/86. Average follow-up was 10.7 months. Mean office BP post-RDN was 164/93, a fall of 22/9 mmHg (P<0.001). In 24% office systolic BP fell ≥ 40 mmHg. Average post-RDN day ABP was 158/92 and night ABP 145/81; fall in day ABP of 12/6 (p<0.001). 18% had a drop in day systolic ABP ≥ 20mmHg; 9% had a fall of ≥30mmHg. A decrease in GFR of ≥25% was seen at 10 month in 5% patients. There were no significant complications. Conclusions: In 246 patients, who had RDN in 16 UK centres there was a significant improvement in BP control with 22/9 mmHg reduction in office BP and 12/6 in day ABP. This suggests that carefully selected patients with resistant hypertension, with few remaining medical options, do have a significant BP reduction following RDN.

Cite

CITATION STYLE

APA

Dasgupta, I., Mark, P., Burchell, A., McKane, W., Martin, U., Nightingale, A., … Sharp, A. (2015). SaO003REAL WORLD EXPERIENCE OF RENAL DENERVATION: THE UK RENAL DENERVATION AFFILIATION REPORT. Nephrology Dialysis Transplantation, 30(suppl_3), iii23–iii24. https://doi.org/10.1093/ndt/gfv145.03

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free